Healthcare - Biotechnology - NASDAQ - US
$ 3.46
2.98 %
$ 173 M
Market Cap
-2.22
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
113.69%
EBIT
Estimate
50.06%
Net Income
Estimate
35.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
scPharmaceuticals Inc.
SCPH has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart SCPH
EBIT FORECAST
EBIT Forecast Chart SCPH
NET INCOME FORECAST
Net Income Chart SCPH